Northstar Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Northstar Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,508	Closed	-$204K	–	97
2023 Q3	$204K	Hold	3,508	–	–	0.15%	91
2023 Q2	$224K	Hold	3,508	–	–	0.15%	76
2023 Q1	$243K	Hold	3,508	–	–	0.18%	75
2022 Q4	$252K	Hold	3,508	–	–	0.2%	83
2022 Q3	$249K	Buy	+3,508	New	+$254K	0.22%	70
2021 Q2	–	Sell	-22,382	Closed	-$1.41M	–	106
2021 Q1	$1.41M	Sell	22,382 -11,272	-33%	-$701K	1.08%	26
2020 Q4	$2.09M	Buy	+33,654	New	+$2.07M	1.75%	13

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northstar Advisory Group's BMY Position: Q4 2023 in Review

Northstar Advisory Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,508 shares — an estimated $204K sold.

Northstar Advisory Group first reported a position in BMY in Q4 2020 and held it in 7 quarters. The position peaked at $2.09M in Q4 2020. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Northstar Advisory Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Northstar Advisory Group sold 3,508 Bristol-Myers Squibb shares in Q4 2023, an estimated $204K.
Northstar Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 7 quarters.
Northstar Advisory Group's Bristol-Myers Squibb position peaked at $2.09M in Q4 2020.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Northstar Advisory Group's 13F filing for Q4 2023, filed 18 Jan 2024.